Merck Kgaa ADR (MKKGY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,677,950 | 1,581,334 | 777,483 | 3,014,731 | 2,327,853 |
| Depreciation Amortization | 1,622,433 | 1,055,736 | 498,306 | 2,309,201 | 1,740,667 |
| Accounts receivable | -523,667 | -426,835 | -312,890 | 85,486 | -105,562 |
| Accounts payable and accrued liabilities | 94,681 | 43,138 | 14,749 | -192,614 | -212,223 |
| Other Working Capital | -1,023,956 | -1,373,592 | -701,631 | -335,451 | -369,466 |
| Other Operating Activity | 239,624 | 395,050 | 309,729 | 81,158 | 307,888 |
| Operating Cash Flow | $3,087,065 | $1,274,830 | $585,746 | $4,962,511 | $3,689,158 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,348,911 | -885,456 | -507,787 | -1,812,518 | -1,384,396 |
| Net Acquisitions | -3,413,188 | -3,406 | N/A | -837,545 | -609,178 |
| Purchase Of Investment | -1,375,795 | N/A | -347,655 | -2,435,807 | -2,016,666 |
| Sale Of Investment | N/A | N/A | 449,845 | N/A | 1,753,862 |
| Purchase Sale Intangibles | -123,903 | -198,660 | -36,873 | -502,094 | -409,051 |
| Other Investing Activity | 1,838,680 | 250,879 | -35,819 | 1,785,465 | -401,355 |
| Investing Cash Flow | $-4,299,214 | $-637,982 | $-441,417 | $-3,300,405 | $-2,657,733 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 945,640 | 918,377 | N/A | 3,025,552 | 751,027 |
| Debt Repayment | 1,260,074 | -1,846,970 | -1,646,620 | -2,968,200 | 678,453 |
| Dividend Paid | -343,657 | -332,614 | N/A | -1,125,384 | -322,183 |
| Other Financing Activity | -882,519 | -857,076 | -48,462 | 2,163 | -820,302 |
| Financing Cash Flow | $979,538 | $-2,118,283 | $-1,695,082 | $-1,065,869 | $286,996 |
| Exchange Rate Effect | -78,316 | -51,084 | -42,140 | -17,314 | -20,892 |
| Beginning Cash Position | 2,942,121 | 2,857,298 | 2,651,659 | 2,144,722 | 2,179,407 |
| End Cash Position | 2,631,194 | 1,323,643 | 1,058,767 | 2,723,646 | 3,475,836 |
| Net Cash Flow | $-310,927 | $-1,533,655 | $-1,592,892 | $578,924 | $1,296,428 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,087,065 | 1,274,830 | 585,746 | 4,962,511 | 3,689,158 |
| Capital Expenditure | -1,361,769 | -893,402 | -513,055 | -1,841,734 | -1,422,882 |
| Free Cash Flow | 1,725,296 | 381,428 | 72,692 | 3,120,777 | 2,266,276 |